News Pain Therapeutics' opioid drug fails to gain FDA approval The US regulator has rejected Pain Therapeutics' abuse-deterrent opioid painkiller drug, Remoxy, for the fourth time.
News FDA refuses to approve Insys opioid painkiller The US regulators have rejected Insys Therapeutics' opioid-based painkiller because of concerns about its safety.
Partner Content Partner Content Pain Therapeutics conference is taking place in London next ... SMi Group reports: To reserve last available seats at the Pain Therapeutics Conference, head on to the event website http://www.pain-therap
News FDA approves Indivior's long-lasting opioid withdrawal thera... Monthly injection will help addicts manage withdrawal symptoms
News FDA delays decision on abuse deterrence data on Endo painkil... Data could be used to fend off generic competition.
News GSK sets up Nucala and Dupixent showdown in COPD GSK has said new data leads it to believe Nucala will be "highly competitive" with rival biologic Dupixent in COPD - if it gets approved by the FDA.
Sales & Marketing Sponsored Health Trends 2025: Reimagining What's Possible Join the conversation, on Tuesday 28th January @ 10 am ET - 3 pm GMT - 4 pm CET, in our webinar sponsored by Syneos Health, entitled ‘Health Trends 2025: Reimagining What's Possibl
